Anew Labs
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
$290MFunding
LeadIC
IDG Capital
Activity from announced rounds
Activity in this selectionBiotech
IDG Capital is the investment firm identified in InfiMaker records and as an angel-round co-lead by Apex Intelligence.
Recorded funding activity
Apex develops models for generating and testing scientific hypotheses. InfiMaker builds desktop five-axis CNC machines, while Anew develops AI-assisted medicines. The investor identity remains separate from former India-focused IDG Ventures and named funds.
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $330M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionSpot Biosystems
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines
$40MSeries B
Role not disclosed